171 related articles for article (PubMed ID: 23664741)
1. Increased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinoma.
Piao S; Ma J; Wang W; Liu Y; Zhang M; Chen H; Guo F; Zhang B; Guo F
Oral Oncol; 2013 Aug; 49(8):796-801. PubMed ID: 23664741
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinoma.
Dai W; Yao Y; Zhou Q; Sun CF
PLoS One; 2014; 9(1):e87148. PubMed ID: 24466336
[TBL] [Abstract][Full Text] [Related]
3. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.
Piao S; Zhao S; Guo F; Xue J; Yao G; Wei Z; Huang Q; Sun Y; Zhang B
J Cancer Res Clin Oncol; 2012 Apr; 138(4):627-35. PubMed ID: 22215147
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma.
Soares CD; de Lima Morais TM; Carlos R; Martins MD; de Almeida OP; Mariano FV; Altemani A
Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353
[TBL] [Abstract][Full Text] [Related]
7. The co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinoma.
Yang DD; Cui BB; Sun LY; Zheng HQ; Huang Q; Tong JX; Zhang QF
Cell Biochem Biophys; 2011 Dec; 61(3):703-10. PubMed ID: 21735131
[TBL] [Abstract][Full Text] [Related]
8. The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases.
Urano M; Hirai H; Tada Y; Kawakita D; Shimura T; Tsukahara K; Kano S; Ozawa H; Okami K; Sato Y; Fushimi C; Shimizu A; Takase S; Okada T; Sato H; Imanishi Y; Otsuka K; Watanabe Y; Sakai A; Ebisumoto K; Togashi T; Ueki Y; Ota H; Sato Y; Saigusa N; Nakaguro M; Hanazawa T; Nagao T
Histopathology; 2018 Dec; 73(6):943-952. PubMed ID: 29993139
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer.
Zhang Y; Yao L; Zhang X; Ji H; Wang L; Sun S; Pang D
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1245-53. PubMed ID: 21691749
[TBL] [Abstract][Full Text] [Related]
10. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
Nagao T; Gaffey TA; Visscher DW; Kay PA; Minato H; Serizawa H; Lewis JE
Am J Surg Pathol; 2004 Mar; 28(3):319-26. PubMed ID: 15104294
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Surg Oncol; 2011 Mar; 103(3):283-9. PubMed ID: 21337558
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma.
Hirai H; Tada Y; Nakaguro M; Kawakita D; Sato Y; Shimura T; Tsukahara K; Kano S; Ozawa H; Okami K; Sato Y; Fushimi C; Shimizu A; Okamoto I; Takase S; Okada T; Sato H; Imanishi Y; Otsuka K; Watanabe Y; Sakai A; Ebisumoto K; Togashi T; Ueki Y; Ota H; Saigusa N; Takahashi H; Ando M; Urano M; Hanazawa T; Nagao T
Virchows Arch; 2020 Aug; 477(2):291-299. PubMed ID: 32103349
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma.
Wang H; Li YP; Chen JH; Yuan SF; Wang L; Zhang JL; Yao Q; Li NL; Bian JF; Fan J; Yi J; Ling R
Tumour Biol; 2013 Jun; 34(3):1635-9. PubMed ID: 23412977
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.
Xu B; Dogan S; Haroon Al Rasheed MR; Ghossein R; Katabi N
Hum Pathol; 2019 Nov; 93():30-36. PubMed ID: 31430492
[TBL] [Abstract][Full Text] [Related]
16. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
[TBL] [Abstract][Full Text] [Related]
17. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
Santana T; Pavel A; Martinek P; Steiner P; Grossmann P; Baněčková M; Skálová A
Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-naïve salivary duct carcinomas.
Yang RK; Zhao P; Lu C; Luo J; Hu R
Hum Pathol; 2019 Feb; 84():173-182. PubMed ID: 30267779
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.
Yang M; Liu YD; Wang YY; Liu TB; Ge TT; Lou G
Tumour Biol; 2014 Feb; 35(2):929-34. PubMed ID: 23979981
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
Masubuchi T; Tada Y; Maruya S; Osamura Y; Kamata SE; Miura K; Fushimi C; Takahashi H; Kawakita D; Kishimoto S; Nagao T
Int J Clin Oncol; 2015 Feb; 20(1):35-44. PubMed ID: 24553861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]